TY - JOUR
T1 - Expanding the use of organs from hepatitis c-viremic donors
T2 - The evidence continues to build
AU - Holscher, Courtenay M.
AU - Durand, Christine M.
AU - Desai, Niraj
N1 - Funding Information:
This work was supported by National Institutes of Health (NIH) grants F32DK109662 (Holscher) and K23CA177321-01A1 (Durand), and an American College of Surgeons Resident Research Scholarship (Holscher). C.M.D. has received research grants from Gilead Sciences, Viiv Healthcare, and Bristol Meyers Squibb, and served as a scientific advisor for Gilead Sciences, Bristol Meyers Squibb, and Merck Pharmaceuticals. N.M.D. has received research grants and served as a scientific advisor for Merck Pharmaceuticals. C.M.H. preparation of manuscript, critical revision. C.M.D. preparation of manuscript, critical revision. N.M.D. preparation of manuscript, critical revision.
Publisher Copyright:
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2018/4/1
Y1 - 2018/4/1
N2 - This commentary argues in favor of use of organs from HCV-viremic donors, more so with the confirmed safety and efficacy of HCV treatment, either as prophylaxis or preemptive treatment, opening possibilities to use all organs from these donors.
AB - This commentary argues in favor of use of organs from HCV-viremic donors, more so with the confirmed safety and efficacy of HCV treatment, either as prophylaxis or preemptive treatment, opening possibilities to use all organs from these donors.
UR - http://www.scopus.com/inward/record.url?scp=85044755040&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044755040&partnerID=8YFLogxK
U2 - 10.1097/TP.0000000000002032
DO - 10.1097/TP.0000000000002032
M3 - Review article
C2 - 29176392
AN - SCOPUS:85044755040
SN - 0041-1337
VL - 102
SP - 546
EP - 547
JO - Transplantation
JF - Transplantation
IS - 4
ER -